AU Stock MarketDetailed Quotes

MXCDA MGC Pharmaceuticals Ltd

Watchlist

0.475
0.0000.00%

20min DelayMarket Closed Nov 7 16:00 AET

2.10MMarket Cap-66P/E (Static)

MGC Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Total revenue

-28.41%3.39M

59.71%4.73M

42.50%2.96M

216.83%2.08M

656.24K

Operating revenue

-28.41%3.39M

59.71%4.73M

42.50%2.96M

216.83%2.08M

--656.24K

Cost of revenue

-33.72%1.94M

76.83%2.92M

-13.23%1.65M

434.01%1.9M

356.64K

Gross profit

-19.85%1.45M

38.12%1.81M

650.24%1.31M

-41.70%174.67K

299.6K

Operating expense

6.70%17.15M

20.11%16.07M

11.70%13.38M

28.28%11.98M

9.34M

Selling and administrative expenses

30.10%13.42M

63.33%10.31M

46.53%6.31M

25.88%4.31M

--3.42M

-Selling and marketing expense

-8.15%926.91K

73.04%1.01M

3.75%583.19K

-2.24%562.13K

--574.98K

-General and administrative expense

34.25%12.49M

62.34%9.3M

52.95%5.73M

31.56%3.75M

--2.85M

Research and development costs

--1.99M

----

--2.87M

Depreciation amortization depletion

99.34%493.73K

-49.60%247.69K

2.14%491.41K

85.23%481.13K

--259.74K

-Depreciation and amortization

99.34%493.73K

-49.60%247.69K

2.14%491.41K

85.23%481.13K

--259.74K

Other operating expenses

-77.40%1.25M

-16.17%5.51M

-8.54%6.58M

157.67%7.19M

--2.79M

Operating profit

-10.07%-15.7M

-18.16%-14.26M

-2.25%-12.07M

-30.59%-11.8M

-9.04M

Net non-operating interest income (expenses)

-60.60%-337.01K

41.95%-209.84K

-193.32%-361.5K

-163.58%-123.25K

193.85K

Non-operating interest income

----

-96.06%301

-38.13%7.63K

-93.89%12.34K

--201.85K

Non-operating interest expense

60.37%337.01K

-43.07%210.14K

172.26%369.14K

1,594.78%135.58K

--8K

Other net income (expenses)

19.05%-5.1M

-109.52%-6.3M

56.08%-3.01M

-198.18%-6.84M

6.97M

Special income (charges)

6.78%-4.8M

-34.37%-5.15M

25.11%-3.83M

-105.58%-5.12M

---2.49M

-Less:Impairment of capital assets

-6.96%4.64M

--4.98M

----

105.27%5.12M

--2.49M

-Less:Other special charges

-1.27%164.22K

29.73%166.32K

--128.21K

----

-Gain on sale of property,plant,equipment

----

---3.7M

----

--3.71K

Other non-operating income (expenses)

74.17%-296.07K

-238.52%-1.15M

148.00%827.6K

-118.23%-1.72M

--9.46M

Income before tax

-1.75%-21.13M

-34.54%-20.77M

17.76%-15.44M

-900.33%-18.77M

-1.88M

Income tax

2.02K

-27.28K

27.32K

Earnings from equity interest net of tax

Net income

-1.76%-21.13M

-30.85%-20.77M

18.06%-15.87M

-722.91%-19.37M

-2.35M

Net income continuous operations

-1.76%-21.13M

-34.77%-20.77M

17.90%-15.41M

-885.98%-18.77M

---1.9M

Net income discontinuous operations

----

22.95%-462.64K

-33.37%-600.43K

---450.19K

Noncontrolling interests

26.27%-309.95K

-20,919.20%-420.38K

71.98%-2K

83.97%-7.14K

-44.53K

Net income attributable to the company

-2.34%-20.82M

-28.21%-20.35M

18.04%-15.87M

-738.47%-19.36M

-2.31M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-2.34%-20.82M

-28.21%-20.35M

18.04%-15.87M

-738.47%-19.36M

-2.31M

Diluted earnings per share

10.13%-7.1

4.82%-7.9

40.71%-8.3

-636.84%-14

-1.9

Basic earnings per share

10.13%-7.1

4.82%-7.9

40.71%-8.3

-636.84%-14

-1.9

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Total revenue	-28.41%3.39M	59.71%4.73M	42.50%2.96M	216.83%2.08M	656.24K
Operating revenue	-28.41%3.39M	59.71%4.73M	42.50%2.96M	216.83%2.08M	--656.24K
Cost of revenue	-33.72%1.94M	76.83%2.92M	-13.23%1.65M	434.01%1.9M	356.64K
Gross profit	-19.85%1.45M	38.12%1.81M	650.24%1.31M	-41.70%174.67K	299.6K
Operating expense	6.70%17.15M	20.11%16.07M	11.70%13.38M	28.28%11.98M	9.34M
Selling and administrative expenses	30.10%13.42M	63.33%10.31M	46.53%6.31M	25.88%4.31M	--3.42M
-Selling and marketing expense	-8.15%926.91K	73.04%1.01M	3.75%583.19K	-2.24%562.13K	--574.98K
-General and administrative expense	34.25%12.49M	62.34%9.3M	52.95%5.73M	31.56%3.75M	--2.85M
Research and development costs	--1.99M	----	----	----	--2.87M
Depreciation amortization depletion	99.34%493.73K	-49.60%247.69K	2.14%491.41K	85.23%481.13K	--259.74K
-Depreciation and amortization	99.34%493.73K	-49.60%247.69K	2.14%491.41K	85.23%481.13K	--259.74K
Other operating expenses	-77.40%1.25M	-16.17%5.51M	-8.54%6.58M	157.67%7.19M	--2.79M
Operating profit	-10.07%-15.7M	-18.16%-14.26M	-2.25%-12.07M	-30.59%-11.8M	-9.04M
Net non-operating interest income (expenses)	-60.60%-337.01K	41.95%-209.84K	-193.32%-361.5K	-163.58%-123.25K	193.85K
Non-operating interest income	----	-96.06%301	-38.13%7.63K	-93.89%12.34K	--201.85K
Non-operating interest expense	60.37%337.01K	-43.07%210.14K	172.26%369.14K	1,594.78%135.58K	--8K
Other net income (expenses)	19.05%-5.1M	-109.52%-6.3M	56.08%-3.01M	-198.18%-6.84M	6.97M
Special income (charges)	6.78%-4.8M	-34.37%-5.15M	25.11%-3.83M	-105.58%-5.12M	---2.49M
-Less:Impairment of capital assets	-6.96%4.64M	--4.98M	----	105.27%5.12M	--2.49M
-Less:Other special charges	-1.27%164.22K	29.73%166.32K	--128.21K	----	----
-Gain on sale of property,plant,equipment	----	----	---3.7M	----	--3.71K
Other non-operating income (expenses)	74.17%-296.07K	-238.52%-1.15M	148.00%827.6K	-118.23%-1.72M	--9.46M
Income before tax	-1.75%-21.13M	-34.54%-20.77M	17.76%-15.44M	-900.33%-18.77M	-1.88M
Income tax	2.02K	0	-27.28K	0	27.32K
Earnings from equity interest net of tax
Net income	-1.76%-21.13M	-30.85%-20.77M	18.06%-15.87M	-722.91%-19.37M	-2.35M
Net income continuous operations	-1.76%-21.13M	-34.77%-20.77M	17.90%-15.41M	-885.98%-18.77M	---1.9M
Net income discontinuous operations	----	----	22.95%-462.64K	-33.37%-600.43K	---450.19K
Noncontrolling interests	26.27%-309.95K	-20,919.20%-420.38K	71.98%-2K	83.97%-7.14K	-44.53K
Net income attributable to the company	-2.34%-20.82M	-28.21%-20.35M	18.04%-15.87M	-738.47%-19.36M	-2.31M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-2.34%-20.82M	-28.21%-20.35M	18.04%-15.87M	-738.47%-19.36M	-2.31M
Diluted earnings per share	10.13%-7.1	4.82%-7.9	40.71%-8.3	-636.84%-14	-1.9
Basic earnings per share	10.13%-7.1	4.82%-7.9	40.71%-8.3	-636.84%-14	-1.9
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall